Quarterly report pursuant to Section 13 or 15(d)

Net Income (Loss) Per Common Share (Tables)

v3.21.2
Net Income (Loss) Per Common Share (Tables)
9 Months Ended
Oct. 30, 2021
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

Three-Month Periods Ended

Nine-Month Periods Ended

    

October 30,

October 31,

    

October 30,

October 31,

    

2021

    

2020

2021

    

2020

Numerator:

 

  

 

  

 

  

 

  

 

Net loss

$

(9,492,000)

$

(4,748,000)

$

(16,970,000)

$

(10,522,000)

Earnings allocated to participating share awards

 

 

 

 

Net loss attributable to common shares — Basic and diluted

$

(9,492,000)

$

(4,748,000)

$

(16,970,000)

$

(10,522,000)

Denominator:

 

  

 

  

 

  

 

  

Weighted average number of common shares outstanding — Basic (a)

 

21,503,340

 

12,177,990

 

18,710,658

 

10,000,383

Dilutive effect of stock options, non-vested shares and warrants (b)

 

 

 

 

Weighted average number of common shares outstanding — Diluted

 

21,503,340

 

12,177,990

 

18,710,658

 

10,000,383

Net loss per common share

$

(0.44)

$

(0.39)

$

(0.91)

$

(1.05)

Net loss per common share — assuming dilution

$

(0.44)

$

(0.39)

$

(0.91)

$

(1.05)

(a) For the three and nine-month periods ended October 30, 2021, the basic earnings per share computation included 21,000 outstanding fully-paid warrants to purchase shares of the Company’s common stock at a price of $0.001 per share.
(b) For the three and nine-month periods ended October 30, 2021 and October 31, 2020 there were 658,000 and 796,000 and 992,000 and 476,000 incremental in-the-money potentially dilutive common shares outstanding. The incremental in-the-money potentially dilutive common stock shares are excluded from the computation of diluted earnings per share, as the effect of their inclusion would be anti-dilutive.